Adamas to Present at Upcoming Evercore ISI Conference
November 24 2020 - 4:03PM
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to
developing and delivering medicines that make a meaningful
difference to people affected by neurological diseases, today
announced that Neil F. McFarlane, the Company’s Chief Executive
Officer, is scheduled to present at the Evercore ISI 3rd Annual
HealthCONx Conference on Tuesday, December 1st at 11:45 am Eastern
Time (8:45 am Pacific).
The presentation will be webcast from the
investor relations section of the Adamas website at
http://ir.adamaspharma.com/events-presentations. Archived versions
of the webcast will be available via replay for 30 days following
the presentation.
About Adamas Pharmaceuticals,
Inc.At Adamas our vision is clear – to deliver innovative
medicines that reduce the burden of neurological diseases on
patients, caregivers and society. We are a fully integrated company
focused on growing a portfolio of therapies to address a range of
neurological diseases. For more information, please visit
www.adamaspharma.com.
Contact
Media:Sarah MathiesonVice
President, Corporate
Communications510-450-3528smathieson@adamaspharma.com
Investors:Peter VozzoManaging
Director, Westwicke443-213-0505peter.vozzo@westwicke.com
Adamas Pharmaceuticals (NASDAQ:ADMS)
Historical Stock Chart
From May 2024 to Jun 2024
Adamas Pharmaceuticals (NASDAQ:ADMS)
Historical Stock Chart
From Jun 2023 to Jun 2024